Bobby is the Chief Business Officer of the BioInnovation Institute in Copenhagen. He holds a BS in Biochemistry from the University of Rochester and a Ph.D. in Biology from the University of Virginia. Bobby has previously been a project leader/scientist at a biotech (Maxygen, business development at pharma (LEO Pharma), and an early-stage therapuetics investor (Novo Seeds/IP Group).
